A phase 1/2 safety and efficacy study of TAK‐754 gene therapy: The challenge of achieving durable factor VIII expression in haemophilia A clinical trials is a research paper published in Haemophilia (2025). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Takeda Pharmaceuticals International
Takeda Pharmaceuticals International
FWCI
3.24
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords